Morgan Annalisa, Punia Vineet
Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Neurohospitalist. 2024 Jul;14(3):291-295. doi: 10.1177/19418744241239382. Epub 2024 Mar 14.
Multiple medications are known to increase epileptogenicity in patients with and without an underlying seizure disorder. Paradoxically, some of these medications include anti-seizure medications (ASMs) and other medications, such as psychotropics, that act on the central nervous system (CNS). This article aims to discuss 3 clinical cases that highlight the gamut of epileptogenic reactivity secondary to CNS drugs ranging from increased epileptogenicity in the form of interictal epileptiform discharges (IEDs) without seizures, increased epileptogenicity on electroencephalogram (EEG) with associated non-epileptic movement disorders, and frank, seizures. We also analyze the relevant literature on the impact of CNS medications on epileptogenicity.
已知多种药物会增加有或无潜在癫痫障碍患者的致痫性。矛盾的是,其中一些药物包括抗癫痫药物(ASMs)和其他作用于中枢神经系统(CNS)的药物,如精神药物。本文旨在讨论3个临床病例,这些病例突出了中枢神经系统药物继发的致痫反应范围,从无癫痫发作的发作间期癫痫样放电(IEDs)形式的致痫性增加,到脑电图(EEG)上致痫性增加并伴有非癫痫性运动障碍,再到明显的癫痫发作。我们还分析了关于中枢神经系统药物对致痫性影响的相关文献。